norfloxacin has been researched along with ascorbic acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Agrawal, A; Dua, K; Garg, V; Himaja, M; Pabreja, K; Ramana, MV; Sara, UV | 1 |
| Alba, MA; Gómez, JJ; Montoya-Estrada, A; Navarrete, JS; Paz, RF; Pérez, NJ; Sánchez, RR | 1 |
| Chasta, H; Goyal, RN; Rana, AR | 1 |
| Gębalski, J; Gospodarek-Komkowska, E; Kwiecińska-Piróg, J; Przekwas, J; Rutkowska, D; Skowron, K; Wałecka-Zacharska, E; Wiktorczyk-Kapischke, N | 1 |
1 review(s) available for norfloxacin and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for norfloxacin and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Investigation of enhancement of solubility of norfloxacin beta-cyclodextrin in presence of acidic solubilizing additives.
Topics: Anti-Infective Agents; Ascorbic Acid; Bacillus subtilis; beta-Cyclodextrins; Citric Acid; Escherichia coli; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Particle Size; Pseudomonas aeruginosa; Solubility; Spectrophotometry, Infrared; Staphylococcus aureus; Technology, Pharmaceutical; Temperature; Wettability | 2007 |
Comparative study of the antimutagenic properties of vitamins C and E against mutation induced by norfloxacin.
Topics: Animals; Anti-Bacterial Agents; Antimutagenic Agents; Ascorbic Acid; Biotransformation; Mutagenicity Tests; Mutagens; Mutation; Norfloxacin; Rats; Salmonella typhimurium; Vitamin E | 2008 |
Electrochemical sensor for the sensitive determination of norfloxacin in human urine and pharmaceuticals.
Topics: Adsorption; Anti-Infective Agents, Urinary; Ascorbic Acid; Biosensing Techniques; Electrochemistry; Electrodes; Graphite; Humans; Hydrogen-Ion Concentration; Limit of Detection; Norfloxacin; Oxidation-Reduction; Pharmaceutical Preparations; Potentiometry; Uric Acid; Urine | 2012 |
The effect of fluoroquinolones and antioxidans on biofilm formation by Proteus mirabilis strains.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Norfloxacin; Proteus mirabilis; Rutin | 2022 |